Increasing Number of Clinically Severe Mycoplasma pneumoniae Infections in Children After the COVID-19 Pandemic: A Single-Center Case Series
- PMID: 39716373
- DOI: 10.1093/jpids/piae132
Increasing Number of Clinically Severe Mycoplasma pneumoniae Infections in Children After the COVID-19 Pandemic: A Single-Center Case Series
Abstract
In 2024, there have been increases in laboratory-confirmed infections caused by Mycoplasma pneumoniae worldwide. This case series highlights the increasing frequency of M. pneumoniae-positive PCR (polymerase chain reaction) specimens and an increased number of hospital admissions with M. pneumoniae clinical syndromes. Within this case series, we observed a change in the epidemiology and clinical burden of childhood M. pneumoniae disease in the post-COVID-19 era.
Keywords: COVID-19; Mycoplasma pneumoniae; children; epidemiology.
© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Comment in
-
Macrolide-Resistant Mycoplasma pneumoniae, North Dakota 2024.J Pediatric Infect Dis Soc. 2025 Jan 20;14(1):piae117. doi: 10.1093/jpids/piae117. J Pediatric Infect Dis Soc. 2025. PMID: 39570300
-
Walking (Pneumonia) Down Memory Lane: Mycoplasma pneumoniae Returns.J Pediatric Infect Dis Soc. 2025 Feb 6;14(2):piaf006. doi: 10.1093/jpids/piaf006. J Pediatric Infect Dis Soc. 2025. PMID: 39868571 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical